|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn567791207 |
003 |
OCoLC |
005 |
20231117032946.0 |
006 |
m o d |
007 |
cr bn||||||abp |
007 |
cr bn||||||ada |
008 |
100323s1979 enka ob 101 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d UIU
|d OCLCO
|d OCLCQ
|d OCLCF
|d N$T
|d E7B
|d EBLCP
|d HEBIS
|d DEBSZ
|d OCL
|d OCLCQ
|d YDXCP
|d OCL
|d MERUC
|d OCLCO
|d OCLCQ
|d STF
|d OCLCQ
|d OCLCO
|d OCLCA
|d VLY
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCLCQ
|d OCL
|
019 |
|
|
|a 651685438
|a 896795370
|a 899003277
|a 974619280
|a 974662475
|a 1162053294
|a 1397390335
|
020 |
|
|
|a 9781483156354
|q (electronic bk.)
|
020 |
|
|
|a 1483156354
|q (electronic bk.)
|
020 |
|
|
|z 0080231942
|
020 |
|
|
|z 9780080231945
|
035 |
|
|
|a (OCoLC)567791207
|z (OCoLC)651685438
|z (OCoLC)896795370
|z (OCoLC)899003277
|z (OCoLC)974619280
|z (OCoLC)974662475
|z (OCoLC)1162053294
|z (OCoLC)1397390335
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP801.P68
|b I57 1978
|
050 |
|
4 |
|a RM101
|b .I55 7th 1978 v.4
|
060 |
|
4 |
|a W3
|b IN54R 7th 1978a v.4
|
060 |
|
4 |
|a QU 90
|b I61106 1978p
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.1 s
|a 615/.7
|2 19
|
111 |
2 |
|
|a International Congress of Pharmacology
|n (7th :
|d 1978 :
|c Paris, France)
|
245 |
1 |
0 |
|a Prostaglandins-immunopharmacology :
|b proceedings of the 7th International Congress of Pharmacology, Paris, 1978 /
|c editor, B.B. Vargaftig.
|
250 |
|
|
|a 1st ed.
|
260 |
|
|
|a Oxford ;
|a New York :
|b Pergamon Press,
|c 1979.
|
300 |
|
|
|a 1 online resource (viii, 226 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in pharmacology and therapeutics ;
|v v. 4
|
504 |
|
|
|a Includes bibliographical references and index.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Front Cover; Prostaglandins -- Immunopharmacology; Copyright Page; Table of Contents; Introduction; Part 1: Prostaglandins, Thromboxanes and Prostacyclin; Chapter 1. Prostaglandins; Prostaglandins and Reproduction; Prostaglandins and Platelet Aggregation; Adrenergic neurotransmission.; REFERENCES; Chapter 2. Prostaglandin Endoperoxides and Thromboxanes: Biochemistry and Biological Role; REFERENCES; Chapter 3. Unstable Metabolites of Arachidonic Acidin Relation to Thrombosis; PRECURSORS AND INTERMEDIATES OF PROSTAGLANDINS; REFERENCES.
|
505 |
8 |
|
|a Chapter 4. The Role of Biologically Active Lipids in Platelet AggregationMechanisms for Aggregation by Arachidonic Acid ; species differences and significance of refractoriness; Mechanism of inhibition of cyclo-oxygenase (CO); Aggregation fully independent from the cyclo-oxygenese pathway; Aggregation by thrombin and phospholipase activity; Aggregation and phospholipases; Phospholipases A2; Phospholipases C; Calcium and thromboxane-mediated aggregation; Control by cyclic AMP of thromboxane-dependent aggregation; Triggering the trigger for generation of thromboxane A2; Concluding remarks.
|
505 |
8 |
|
|a Chapter 8. Participation of Prostaglandins in Inflammatory PainABSTRACT; INTRODUCTION; SUMMARY AND CONCLUSIONS; REFERENCES; Part II: Pharmacology of Platelets; Chapter 9. Introductory Remarks; Chapter 10. Factors Affecting the Formation and Actionsof Cyclic AMP in Blood Platelets; INTRODUCTION; ACTIVATION OF PLATELET ADENYLATE CYCLASE BY INHIBITORY AGONISTS; INHIBITION OF PLATELET ADENYLATE CYCLASE BY AGGREGATING AGENTS; INHIBITION OF PLATELET ADENYLATE CYCLASE BY ADENOSINE ANALOGUES; STUDIES OF THE MECHANISM OF ACTION OF CYCLIC AMP IN PLATELETS; ACKNOWLEDGEMENTS; REFERENCES.
|
505 |
8 |
|
|a Chapter 11. The Role of Calcium Ions in the Regulation of Platelet Function and Their Pharmacological ControlINTRODUCTION; THE ROLE OF CALCIUM IONS IN PLATELET FUNCTION; THE MOBILIZATION OF CA2+I0NS; REVERSIBILITY OF PLATELET ACTIVATION; PHARMACOLOGICAL CONTROL OF Ca2+-LEVELS; CONCLUSION; REFERENCES; Chapter 12. Platelet Secretion (Release Reaction) -Mechanism and Pharmacology; PLATELET SECRETION; STORAGE GRANULES AND THEIR CONSTITUENTS; DIFFERENTIAL SECRETION; INDUCTION OF PLATELET SECRETION, THE BASIC PLATELET REACTION; TEE BASIC PLATELET REACTION; THE MECHANISM OF PLATELET SECRETION.
|
520 |
|
|
|a Advances in Pharmacology and Therapeutics, Volume 4: Prostaglandins-Immunopharmacology contains the proceedings of the 7th International Congress of Pharmacology held in Paris, France, in 1978. The papers explore advances in the understanding of prostaglandins, their immunopharmacology, and their therapeutic applications. Topics covered range from the biochemistry of prostaglandins, thromboxanes, and prostacyclin to the pharmacology of blood platelets and pharmacological approaches to enhancement of immunity. This volume is comprised of 23 chapters and opens with a discussion on the discovery.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Prostaglandins
|v Congresses.
|
650 |
|
0 |
|a Immunopharmacology
|v Congresses.
|
650 |
|
0 |
|a Prostaglandins.
|
650 |
|
0 |
|a Thromboxanes.
|
650 |
|
0 |
|a Blood platelets
|x Congresses.
|
650 |
|
0 |
|a Immune response
|x Regulation
|v Congresses.
|
650 |
|
2 |
|a Blood Platelets
|x drug effects
|0 (DNLM)D001792Q000187
|
650 |
|
2 |
|a Immunity
|x drug effects
|0 (DNLM)D007109Q000187
|
650 |
|
2 |
|a Prostaglandins
|0 (DNLM)D011453
|
650 |
|
2 |
|a Thromboxanes
|0 (DNLM)D013931
|
650 |
|
6 |
|a Prostaglandines
|0 (CaQQLa)201-0031328
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Sang
|0 (CaQQLa)201-0016716
|x Plaquettes
|0 (CaQQLa)201-0016716
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a Sang
|0 (CaQQLa)201-0005812
|x Plaquettes, Effets des m�edicaments sur les
|x Congr�es.
|0 (CaQQLa)201-0378208
|
650 |
|
6 |
|a R�eaction immunitaire
|0 (CaQQLa)201-0018274
|x R�egulation
|0 (CaQQLa)201-0018274
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Immunopharmacologie
|0 (CaQQLa)201-0072475
|v Congr�es.
|0 (CaQQLa)201-0378219
|
650 |
|
6 |
|a Prostaglandines.
|0 (CaQQLa)201-0031328
|
650 |
|
6 |
|a Thromboxanes.
|0 (CaQQLa)201-0031329
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Thromboxanes.
|2 fast
|0 (OCoLC)fst01150439
|
650 |
|
7 |
|a Immune response
|x Regulation.
|2 fast
|0 (OCoLC)fst00967872
|
650 |
|
7 |
|a Blood platelets.
|2 fast
|0 (OCoLC)fst00834782
|
650 |
|
7 |
|a Immunopharmacology.
|2 fast
|0 (OCoLC)fst00968030
|
650 |
|
7 |
|a Prostaglandins.
|2 fast
|0 (OCoLC)fst01079463
|
655 |
|
2 |
|a Congress
|0 (DNLM)D016423
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 (OCoLC)fst01423772
|
655 |
|
7 |
|a Conference papers and proceedings.
|2 lcgft
|
655 |
|
7 |
|a Actes de congr�es.
|2 rvmgf
|0 (CaQQLa)RVMGF-000001049
|
700 |
1 |
|
|a Vargaftig, B. B.
|
776 |
0 |
8 |
|i Print version:
|a International Congress of Pharmacology (7th : 1978 : Paris, France).
|t Prostaglandins-immunopharmacology.
|b 1st ed.
|d Oxford ; New York : Pergamon Press, 1979
|w (DLC) 78041029
|w (OCoLC)4593134
|
830 |
|
0 |
|a Advances in pharmacology and therapeutics ;
|v v. 4.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780080231945
|z Texto completo
|